AI Article Synopsis

  • The study aimed to explore the clinical and pathological factors related to hypothalamus invasion in adamantinomatous craniopharyngiomas (ACPs) and their postoperative outcomes after surgical resection using the expanded endonasal approach (EEA).
  • Researchers analyzed 93 ACP specimens, focusing on immunohistochemical markers like TGF-β1 and β-catenin, alongside patient clinical data to find links between these factors.
  • Results revealed that recurrent patients had increased endocrinological dysfunction and lower rates of complete tumor resection, with higher expression levels of TGF-β1 and β-catenin associated with worse outcomes and hypothalamus invasion, highlighting the potential of TGF-β1 as a progn

Article Abstract

Objective: To investigate the clinical and pathological factors associated with preoperative hypothalamus invasion and postoperative outcomes of adamantinomatous craniopharyngiomas (ACPs) after the expanded endonasal approach (EEA) resection.

Methods: Ninety-three specimens of ACPs, consisting of 71 primary and 22 recurrent tumors, were investigated for the expression of TGF-β1, SMAD2, SMAD3, and β-catenin by immunohistochemistry staining. The clinical information of relevant patients, including the extent of resection, hypothalamus invasion, endocrinopathy, complications, and prognosis, was reviewed. The relationships between the expression of these immunopathological markers and clinical factors were analyzed.

Results: Endocrinological dysfunctions were more common in recurrent patients and primary patients with hypothalamus invasion in the comparisons. For recurrent patients, the rate of gross total resection (GTR) was significantly lower than for primary patients (63.6% vs. 90.1%, = 0.007). According to radiological and intraoperative findings, invasive ACPs (IACPs) included 48 (67.6%) cases in primary tumors. The expression of TGF-β1 and β-catenin was significantly higher in recurrent tumors ( = 0.021 and = 0.018, respectively) and IACPs ( = 0.008 and = 0.004, respectively). The expression level of TGF-β1 was associated with hypothalamus involvement (Puget grade, = 0.05; Vile grade, = 0.002), postoperative endocrinopathy ( = 0.01), and pituitary stalk preservation ( = 0.008) in primary patients. In addition, the extent of resection, treatment history, hypothalamic invasion, and level of TGF-β1 expression had significant influences on tumor recurrence/progression after surgery separately.

Conclusion: Our study demonstrated the potential role of TGF-β1 in the regulation of hypothalamus invasion in ACPs and the prediction of prognosis after EEA surgery. The TGF-β signaling pathway may represent a crucial mechanism in the aggressive behavior and progression of ACPs.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579895PMC
http://dx.doi.org/10.3389/fendo.2023.1167776DOI Listing

Publication Analysis

Top Keywords

hypothalamus invasion
16
primary patients
12
tgf-β signaling
8
signaling pathway
8
clinical factors
8
adamantinomatous craniopharyngiomas
8
recurrent tumors
8
expression tgf-β1
8
extent resection
8
recurrent patients
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!